Arcturus Therapeutics Holdings Inc.
ARCT· Nasdaq
Released Aug 10, 2020, after the close
10-Q filed Aug 10, 2020, 41 days after period end · 0001564590-20-038980
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $2.32M | $10.15M | $2.39M |
| Net Income | -$10.26M | -$685.00K | -$9.95M |
| EPS Diluted | -$0.55 | -$0.07 | -$0.99 |
Arcturus Therapeutics Holdings Inc. · CIK 1768224 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.